Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TEB-17231 |
Trade Name | |
Synonyms | TEB 17231|TEB17231|YL-17231|YL17231 |
Drug Descriptions |
TEB-17231 inhibits KRAS, resulting in reduced downstream signaling and potentially leading decreased cell viability and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 2627). |
DrugClasses | KRAS Inhibitor 18 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TEB-17231 | TEB-17231 | 0 | 1 |